Dr. Ruifeng Zhou, MD

Dr. Zhou practices at Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health.

Dr. Zhou's NPI, 1376816736, was assigned on February 16, 2012. Dr. Zhou holds Massachusetts license 1017376.

Dr. Zhou's primary practice is Baystate Medical Center, at 759 Chestnut Street, Springfield, MA 01199 in Hampden County. The practice phone is (413) 794-0000.

Dr. Zhou's primary practice is Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health. Dr. Zhou is also affiliated with Allegheny General Hospital. The medical group on file is Baystate Medical Practices. Dmand AI also links Dr. Zhou to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhou practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Zhou's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zhou is licensed in Massachusetts.

CMS data shows 938 Medicare services from Dr. Zhou across 6 procedure codes in 2024, for 208 Medicare patients. Medicare paid $71,736 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 208 Medicare patients who saw Dr. Zhou in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhou's median patient age at 71, with 41% women.

In 2024, Dr. Zhou wrote 392 Medicare Part D claims for 127 patients. 67% of them were for generic drugs. CMS names the drug for 226 of them, across 7 drugs with 11 or more claims each, at $991,532 in total drug cost. In 2023, CMS named 382 claims across 16 drugs.

Dr. Zhou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhou as offering telehealth.

Dmand AI links 30 papers to Dr. Zhou, published from 2010 to 2023. 2022 was the busiest year, with 6. The most frequent topics are COVID-19, SARS-CoV-2 and Cricetinae. Dr. Zhou has published most often in bioRxiv. Dr. Zhou's most frequent co-authors are Laura L. Gibson, MD, David Dionne McManus, MD and Bruce Allen Barton, MD.

CMS Open Payments shows 43 general payments to Dr. Zhou from 22 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 54% of the total. Incyte Corporation paid the most, $230.